Routine assessment of myocardial viability before revascularization requires further randomized trials to conclusively determine its ability to guide treatment and avoid unnecessary procedures.
Does routine assessment of myocardial viability before revascularization identify patients who benefit most and avoid unnecessary procedures?
Highlights the need for future randomized trials to determine the value of routine myocardial viability testing prior to revascularization.
Absolute Event Rate: 0% vs 0%
In conclusion, further randomized trials will be needed to conclusively assess whether routine assessment of myocardial viability before revascularization can: (a) identify those patients who might benefit most from revascularization; (b) choose the most appropriate revascularization approach; (c) avoid unnecessary procedures and risk in those patients with minimal or absent viability.
Himbert et al. (Wed,) reported a other. Routine assessment of myocardial viability before revascularization requires further randomized trials to conclusively determine its ability to guide treatment and avoid unnecessary procedures.